Opinion

Most Recent

image: Opinion: Lab Safety Lapses Tell Larger Story

Opinion: Lab Safety Lapses Tell Larger Story

By | July 22, 2014

Recent security issues within US government labs reveal deficiencies in biorisk management programs.

1 Comment

image: Opinion: Bumblebees in Trouble

Opinion: Bumblebees in Trouble

By | June 30, 2014

Commercialization has sickened wild bumblebees around the world. Can we save them? 

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: Opinion: GM Salmon: Just the Beginning

Opinion: GM Salmon: Just the Beginning

By | June 1, 2014

Sound risk management concerning genetically engineered food animals is critical. 

2 Comments

image: Opinion: Sizing Up GM Salmon

Opinion: Sizing Up GM Salmon

By | June 1, 2014

On the potential benefits and risks of genetically modified fish entering the marketplace 

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry.

0 Comments

image: Opinion: Hone Your Craft, Sell Your Skills

Opinion: Hone Your Craft, Sell Your Skills

By | May 12, 2014

In an ever-changing job market, PhD scientists should be careful not to confuse their passion with their research foci, and to avoid academic tunnel vision.

0 Comments

image: Opinion: Latent Value in the Literature

Opinion: Latent Value in the Literature

By | April 28, 2014

With scientific budgets eroding, the biomedical community needs to get more return from the data it has already generated.

2 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

Popular Now

  1. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  2. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS